N-cyclohexyl-2-(1H-indazol-5-yl)imidazo[1,2-a]pyridin-3-amine | 1093302-75-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 咪唑并吡啶类
• 英文名称: N-cyclohexyl-2-(1H-indazol-5-yl)imidazo[1,2-a]pyridin-3-amine
• CAS: 1093302-75-0
• 化学式: C₂₀H₂₁N₅
• 分子量: 331.42
• InChiKey: GJTDOHMDTQOMGR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.2
• 重原子数：
  25
• 可旋转键数：
  3
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  58
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  1H-吲唑-5-甲醛 、 2-氨基吡啶 、 异氰环已烷 在 scandium tris(trifluoromethanesulfonate) 作用下， 以 甲醇 为溶剂， 生成 N-cyclohexyl-2-(1H-indazol-5-yl)imidazo[1,2-a]pyridin-3-amine
  参考文献：
  名称：

  Scaffold oriented synthesis. Part 4: Design, synthesis and biological evaluation of novel 5-substituted indazoles as potent and selective kinase inhibitors employing heterocycle forming and multicomponent reactions

  摘要：

  We report the synthesis and biological evaluation of 5-substituted indazoles as kinase inhibitors. The compounds were synthesized in a parallel synthesis fashion from readily available starting materials employing heterocycle forming and multicomponent reactions and were evaluated against a panel of kinase assays. Potent inhibitors were identified for Gsk3 beta, Rock2, and Egfr. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.01.001

文献信息

• [EN] SMALL MOLECULE INHIBITION OF TRANSCRIPTION FACTOR SALL4 AND USES THEREOF<br/>[FR] INHIBITION PAR DES PETITES MOLÉCULES DU FACTEUR DE TRANSCRIPTION SALL4 ET SES UTILISATIONS
  申请人：DANA FARBER CANCER INST INC

  公开号：WO2019070943A1

  公开（公告）日：2019-04-11

  Provided herein are compounds that interrupt the function of SALL4. Also described are pharmaceutical compositions and medical uses of these compounds.

  本文提供了一些干扰SALL4功能的化合物。同时还描述了这些化合物的药物组合物和医疗用途。
• 5-SUBSTITUTED INDAZOLES AS KINASE INHIBITORS
  申请人：Akritopoulou-Zanze Irini

  公开号：US20090203690A1

  公开（公告）日：2009-08-13

  The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, wherein A, R 1 , R 2 , R 3 and m, are defined in the description. The present invention relates also to methods of making said compounds, and compositions containing said compounds which are useful for inhibiting kinases such as Glycogen Synthase kinase 3 (GSK-3), Rho kinase (ROCK), Janus Kinases (JAK), Cdc7, AKT, PAK4, PLK, CK2, KDR, MK2, JNK1, aurora, pim 1 and nek 2.

  本发明涉及式（I）的化合物或药物可接受的盐，其中A，R1，R2，R3和m在说明书中定义。本发明还涉及制备所述化合物的方法，以及含有所述化合物的组合物，该组合物对抑制激酶如糖原合成酶激酶3（GSK-3），Rho激酶（ROCK），Janus激酶（JAK），Cdc7，AKT，PAK4，PLK，CK2，KDR，MK2，JNK1，极光激酶，pim 1和nek 2有用。
• Small molecule inhibition of transcription factor SALL4 and uses thereof
  申请人：Dana-Farber Cancer Institute, Inc.

  公开号：US11530209B2

  公开（公告）日：2022-12-20

  Provided herein are compounds that interrupt the function of SALL4. Also described are pharmaceutical compositions and medical uses of these compounds.

  本文提供了能干扰 SALL4 功能的化合物。还描述了这些化合物的药物组合物和医疗用途。
• 5-HETEROARYL SUBSTITUTED INDAZOLES AS KINASE INHIBITORS
  申请人：Abbott Laboratories

  公开号：EP2167491A1

  公开（公告）日：2010-03-31
• US20140343066A1
  申请人：——

  公开号：US20140343066A1

  公开（公告）日：2014-11-20